HemaQuest Pharmaceuticals Receives $4,000,000 Series B Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=37c0f677-bbd5-4a15-be27-f940911161d4&Preview=1 -
Date
7/28/2010 -
Company Name
HemaQuest Pharmaceuticals -
Mailing Address
1229 Madison Street Seattle, WA 98104 -
Company Description
HemaQuest is a company developing proprietary small molecule therapeutics to treat serious blood disorders. -
Website
http://www.hemaquest.com -
Transaction Type
Venture Equity -
Transaction Amount
$4,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The financing will be used to help push HemaQuest’s two lead drug candidates through mid-stage clinical trials designed to show they are safe and effective. -
M&A Terms
-
Venture Investor
Latterell Venture Partners
